[{"Assets_0_Q3_USD":317041000.0,"CommonStockSharesOutstanding_0_Q3_shares":32208000.0,"EarningsPerShareBasic_1_Q3_USD":-0.13,"EarningsPerShareBasic_3_Q3_USD":-0.27,"EarningsPerShareDiluted_1_Q3_USD":-0.13,"EarningsPerShareDiluted_3_Q3_USD":-0.27,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-66817000.0,"NetIncomeLoss_1_Q3_USD":-4084000.0,"NetIncomeLoss_3_Q3_USD":-7079000.0,"StockholdersEquity_0_Q3_USD":175062000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":32182000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":29321000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":32182000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":29321000.0,"Ticker":"JNCE","CIK":"1640455","name":"JOUNCE THERAPEUTICS, INC.","OfficialName":"Jounce Therapeutics Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"354419760.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171113"}]